Roivant Sciences Ltd. - Common Shares — Cash Flow (NASDAQ:ROIV) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Quarterly Annual

Cash from operating activities -677.73 M-843.39 M-765.27 M-839.45 M-750.35 M -816.47 M Cash from investing activities 303.3 M-44.27 M5.2 B-1.77 B-682.33 M 684.64 M Cash from financing activities 306.79 M499.46 M419.36 M-1.22 B134.24 M 140.49 M Free cash flow -677.73 M-843.39 M-765.27 M-839.45 M-758.56 M -821.06 M

News

Roivant Sciences Ltd. (ROIV) Discusses FDA Approval of LISRAYA as First Oral Targeted Therapy for Dermatomyositis Transcript

Why Is Arbutus Biopharma Stock Gaining Friday? - Arbutus Biopharma (NASDAQ:ABUS)

Roivant Sciences Stock: The Balance Sheet Has Become A Strategic Weapon (NASDAQ:ROIV)

Roivant Sciences Ltd. (ROIV) Reports Q1 Loss, Misses Revenue Estimates

Fortrea Holdings Inc. (FTRE) Surpasses Q2 Earnings and Revenue Estimates

ValuEngine Weekly Market Summary And Commentary

ValuEngine Weekly Market Summary And Commentary

Roivant Sciences Ltd. (ROIV) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

Roivant Sciences Ltd. (ROIV) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

Roivant: Immunovant's Rheumatoid Arthritis Win Validates The Buy (NASDAQ:ROIV)

Roivant Sciences Ltd. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:ROIV) 2026-05-21

These Two Biotech Stocks Rocketed — And One Just Broke Out